Castellum, Inc. Announces Signing of Non-Binding LOI for East Coast Government Contractor
18 janv. 2023 09h00 HE
|
Castellum, Inc.
BETHESDA, Md., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare, data analytics, software, and IT services company focused on the federal...
Castellum, Inc. Announces Alan R. Lynn to Join Advisory Board
13 janv. 2023 06h55 HE
|
Castellum, Inc.
POTOMAC, Md., Jan. 13, 2023 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE American: CTM) announces Alan “Al” Lynn has joined the Company’s Advisory Board. Castellum’s Advisory Board seats experienced...
Hoverfly Technologies Secures Landing Ring Design Patent
04 janv. 2023 11h00 HE
|
Hoverfly Technologies, Inc.
SANFORD, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Hoverfly Technologies Inc. announced today that it has been issued U.S. Patent No. 11,518,542 from the U.S. Patent Office for the "Landing Structure...
Castellum Announces That It Is One Of The Winners Of The $900 Million Air Force Architecture And Integration Directorate Multiple Award Indefinite Delivery/Indefinite Quantity Contract (AFLCMC/XA) (MAC IDIQ)
12 déc. 2022 06h55 HE
|
Castellum, Inc.
POTOMAC, Md., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) is pleased to announce that it is one of the winners of the Architecture and Integration Directorate Multiple...
Kane Biotech Receives an Additional $425K USD of Funding for its DispersinB® Hydrogel from the United States Department of Defense
04 oct. 2022 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has received an additional $425,000 USD of...
Immuron new MTEC project proposal “Development of Oral Immunotherapy for the Prevention of Bacterial Diarrheal Disease”
19 avr. 2022 07h33 HE
|
Immuron Limited
Key Highlights: Immuron’s request for AU$5.4M (US$4M) additional funding from the U.S. Department of Defense for Travelan considered to be ‘eligible for award’Travelan Investigational New Drug (IND)...
Castellum, Inc. Announces $950,000 New Revolving Credit Facility from Live Oak Bank
04 avr. 2022 09h00 HE
|
Castellum, Inc.
POTOMAC, Md., April 04, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (OTC: ONOV) announces that it has secured a new $950,000 revolving accounts receivable-based credit facility from Live Oak Bank. "We...
Castellum Announces Signing Definitive Agreement to Acquire Lexington Solutions Group
25 févr. 2022 09h00 HE
|
Castellum, Inc.
POTOMAC, Md., Feb. 25, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (OTC: ONOV) announces the signing of a “Definitive Purchase Agreement” to acquire Lexington Solutions Group (“LSG”), a $4 million...
Castellum, Inc. Announces Appointment of Former Congressman and NBA Player Tom McMillen to Company's Advisory Board
03 févr. 2022 09h00 HE
|
Castellum, Inc.
POTOMAC, Md., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (OTC: ONOV) proudly announces that former Congressman, NBA player, Olympian, and Rhodes Scholar Tom McMillen joined the Company's...
Castellum, Inc. Announces Q4 Record Revenue
27 janv. 2022 09h00 HE
|
Castellum, Inc.
POTOMAC, Md., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (OTC: ONOV) announces that it generated approximately $9.5 million in unaudited revenue in the fourth quarter ended December 31,...